Nasdaq

Core One Labs Signs Letter of Intent with GMP Manufacturing Partner for Production of Proprietary Psychedelic Compounds

VANCOUVER, BC / ACCESSWIRE / September 23, 2022 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce it has entered into a ...
Nasdaq

Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy

VANCOUVER, BC / ACCESSWIRE / May 1, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce that its wholly-owned subsidiaries ...
WFMZ-TV

Core One Labs Inc. Provides Clarification on Terms of Definitive Agreement to Acquire Micro-Cultivation Facility in Canada

VANCOUVER, British Columbia, Nov. 5, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") is issuing this news release to ...
The Globe and Mail

Core One Labs Vocan Expands Product Commercialization Team

VANCOUVER, BC / ACCESSWIRE / April 6, 2021 /Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") is pleased to announce its wholly-owned subsidiary ...
Business Insider

REPEAT - Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent

VANCOUVER, British Columbia, June 14, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is ...
Business Insider

World Renowned Physician Joins Core One Labs as Chief Medical Officer

VANCOUVER, British Columbia, May 05, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce it has ...
WIVB-TV

Core One Labs' Acquires GMP Drug Inc.: Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and Other Drug Developers

VANCOUVER, BC / ACCESSWIRE / January 13, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN: A3CSSU) (the "Company" or "Core One"), is pleased to ...
Benzinga.com

Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds

GMP Drug Inc., a wholly-owned subsidiary of Core One Labs Inc. CLABF COOLLD (WKN: A3CSSU) has entered into a non-binding letter of intent with Zollaris Laboratories Corporation, an arms-length party, ...
High Times

Core One Labs Nearing Commercial Mushroom Production in Canada

A Canadian biotech company says that it is ready to initiate commercial production of psilocybin mushrooms. Core One Labs Inc., which is based in Vancouver, is “set to begin commercial production of ...